Erenumab in migraine: Indication of considerable added benefit for certain patients

(Institute for Quality and Efficiency in Health Care) The first drug of a new drug class can reduce the number of headache days if other prophylactic medications have failed or have not been an option.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news